The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...

Craig Collins struggled with his condition before committing to the long path through surgeries—and fitness—to muscle up.

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

Crohn’s disease and ulcerative colitis (UC) are both types of inflammatory bowel disease (IBD) that share similar symptoms but differ in their affected areas, disease progression, and treatment ...

There isn’t any one test used to diagnose Crohn’s disease because it can present with different symptoms. Most doctors use a mix of tests and procedures to confirm a suspected case of Crohn ...

Eating a Mediterranean-style diet can help people manage IBD symptoms, and a new cookbook from Crohn's & Colitis Ireland ...

Though the two have similar symptoms, they require different ... July 17, 2023 — Chronic inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, is on the rise worldwide.

Eli Lilly has received approval from the US FDA for Omvoh to treat moderately to severely active Crohn's disease in the adult ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to developing novel drugs targeting ...

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and ...